Zepbound® 2.5 mg is the initial dose in the once-weekly injectable treatment regimen for chronic weight management in adults with obesity or overweight-related health conditions. Each prefilled pen delivers 2.5 mg of tirzepatide in 0.5 mL, designed for subcutaneous injection. This starting dose is used for the first 4 weeks of therapy to help minimize gastrointestinal side effects before progressing to higher maintenance doses. The 4-pack provides a one-month supply of the 2.5 mg dose.

Features:

• Starting Dose: 2.5 mg weekly is the recommended initiation dose to assess tolerability.

• Once-Weekly Dosing: Convenient weekly injection with no mixing required.

• Prefilled, Ready-to-Use Pens: Simple, easy-to-use pens that require no dose preparation.

• GLP-1 and GIP Receptor Agonist: Tirzepatide works by reducing appetite and food intake to support weight loss.

• 4-Pack for 4 Weeks: One pen for each week, providing a full month of therapy at the 2.5 mg dose.